Goldman Sachs Group Inc Cns Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 14, 2024
BUY
$0.19 - $292.65 $3,524 - $5.43 Million
18,549 New
18,549 $3,000
Q3 2022

Nov 10, 2022
BUY
$0.19 - $292.65 $3,524 - $5.43 Million
18,549 New
18,549 $0

Others Institutions Holding CNSP

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About CNS Pharmaceuticals, Inc.

CNSP Quotes by TradingView
  • Ticker CNSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,032,500
  • Market Cap $4.4M
  • Description
  • CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....
More about CNSP
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email